Dengue EW32: the curve bends,
the emergency holds.

The Pan American Health Organization's week-32 situation report (published September 4) is the first full-season readout since 2024's record of more than 13 million cases. The headline: 1,567,004 suspected cases across the Americas so far this year, down 58% against the same period of 2025, and 65% below the five-year average. Nineteen countries still report multiple serotypes circulating together.

Two readings are possible and both are true. The epidemic curve has bent, 2026 is tracking closer to a normal endemic year than to the historic peak. And the region remains under a formal Grade 3 emergency, because "half of the worst year ever recorded" is still 1.5 million infections.

The week's ledger

Week 32 alone: 26,078 new suspected cases across 14 reporting countries, 7,275 lab-confirmed, 65 severe, 11 deaths. Cumulative: 477,051 confirmed, 3,086 severe, 492 deaths, case fatality 0.031%. The Andean sub-region carried most of the week's new cases; the Caribbean reported almost none, the southern-hemisphere season is winding down while the north waits for its own.

Sub-region rows read from the sitrep's tables for week 32, 2026. Totals may not sum exactly to the regional figure because of reporting lags and unassigned cases. Checked 2026-09-04.

Four seasons, one axis

Where 2026 sits against the years either side of it. The bend is real; so is the floor.

Grade A source: these figures are quoted directly from the sitrep tables, not from news coverage of them. Checked 2026-09-04.

Why a Grade 3 emergency does not expire with the curve

PAHO grades outbreaks on a three-tier scale, and grade 3 is the top: sustained multi-country transmission, health systems under measurable strain, and a formal coordination response. What downgrades it is not the case count falling, it is the count falling and the responding infrastructure standing down. Neither has happened. Nineteen countries still report co-circulating serotypes, which is the specific condition that makes second infections more dangerous than first ones.

There is also a calendar reason the emergency outlives the headline. The Americas straddle the equator: the southern-hemisphere season peaks in the first months of the year and is now winding down, but the northern-hemisphere season, Mexico, Central America, the Caribbean, is only starting. A September snapshot is structurally a between-seasons picture. The grade reflects the whole year, not the week.

The serotype arithmetic behind "second infection is worse"

Dengue has four serotypes. First infection with any of them is usually survivable and confers lifelong immunity to that one serotype only. A second infection with a different serotype carries a higher risk of severe disease, because the antibodies from the first infection can help the second virus enter cells, the mechanism called antibody-dependent enhancement. This is not a hypothesis; it is the reason vaccine candidates have struggled for decades and why the one licensed dengue vaccine is restricted to people with evidence of prior infection.

For the region it means nineteen countries with co-circulation are sitting on the exact precondition for severe second cases. For a household it means the same thing in one sentence: your first dengue does not vaccinate you against the next one, and in a specific and well-understood way it can make it worse.

What does not change for a household

A falling regional curve does not reach into your patio. Week-by-week regional numbers are for ministries; mosquito control is local and container-shaped. The ten-minute yard survey and the warning signs page carry the same weight in a quiet September as in a record March. Serotype turnover, the same reason nineteen countries now report co-circulation, is exactly why a dengue infection in your past does not make a second one milder. The hospital-now signs do not soften because the regional count fell.

We will log the next sitrep when the record moves.